Tue, 19 Nov 2013 | COMMERCIAL PROPERTY
ITV Wales’ headquarters at Culverhouse Cross in Cardiff has been placed on the market, Wales Online has revealed.
Property adviser Lambert Smith Hampton has been hired to market the site for sale, which has outline planning consent for up to 250 new homes, though a full planning application for the site to be redeveloped for residential use was rejected by Vale of Glamorgan councillors in October.
The TV broadcaster has since lodged a planning inspectorate appeal, and could send a new planning application to the unitary authority.
The site, with its 17.59 acres of development land, is expected to gain bids of about £17 million from housing developers.
The 138,000 sq. ft. studio and office property at Culverhouse Cross is only half occupied at present, and has short-term leases with 35 tenants such as creative industry businesses. Costs to ITV Wales to maintain the property have led to losses of £800,000, despite the rent from its tenants.
ITV Wales will leave the 1980s built site in the summer 2014 and move into its new home – an 11,000 sq. ft. space with more up-to-date facilities at the 3 Assembly Square office site in Cardiff Bay.
Indycube, a South Wales-based community business that offers space and facilities for fledgling start-ups and self-employed workers, has made its interest in the site known. It wants to buy the property as it stands and bring in more tenants, rather than tearing it down.
____________________________________________________________________________
Related information:
Tips on acquisition strategies
BBC Wales headquarters for sale
This unique and renowned freehold bar and restaurant in the heart of York City Centre offers over 250 covers across its spacious interior, pavement seating, and a rare rooftop terrace.
FREEHOLD
A well established and strongly profitable engineering business, located in the Midlands. The company will be an attractive acquisition for both a larger trade buyer and also those looking for a stable engineering business.
This European pharmacy manufacturer specialises in providing custom clinical trial batches for leading pharmacy companies across the continent, playing a crucial role in their R&D efforts.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.